AMONDYS 45 FDA approval date
The FDA approved AMONDYS 45 on 25 Feb 2021.
- FDA approval date
- 25 Feb 2021
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as CASIMERSEN
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2021-02-25Day | AMONDYS 45 | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA213026", "applicant_as_listed_by_fda": "SAREPTA THERAPS INC", "brand_names": ["AMONDYS 45"], "active_ingredients": ["CASIMERSEN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210225", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |